再鼎医药(09688):zocilurtatug pelitecan在一线广泛期小细胞肺癌中展现出高缓解率、令人鼓舞的持久性及耐受良好的安全性特征
Last Update:
23 10 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.